Key points are not available for this paper at this time.
Our results reinforce that genomic surveillance programs are essential for countries to make evidence-driven interventions toward the emergence and circulation of novel SARS-CoV-2 variants.
Jiménez-Silva et al. (Thu,) studied this question.